As countries introduce hormonal IUD into their contraception method mix, it is important for
them to develop robust assumptions for the quantification process as they prepare for
health worker trainings, and the introduction and scale-up of this new product. This document provides guidance on forecasting approaches for hormonal IUD during introduction and early scale-up and includes examples of key evidence from countries that have begun introductions, to assist others in determining reasonable assumptions.